Susquehanna International Group’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$172K Sell
121,147
-1,260,594
-91% -$1.79M ﹤0.01% 5639
2025
Q1
$2.11M Buy
1,381,741
+1,302,694
+1,648% +$1.99M ﹤0.01% 2223
2024
Q4
$196K Buy
79,047
+16,639
+27% +$41.3K ﹤0.01% 5323
2024
Q3
$71.8K Sell
62,408
-144,192
-70% -$166K ﹤0.01% 5211
2024
Q2
$227K Buy
206,600
+83,140
+67% +$91.5K ﹤0.01% 4568
2024
Q1
$153K Sell
123,460
-30,149
-20% -$37.4K ﹤0.01% 4822
2023
Q4
$161K Buy
153,609
+29,759
+24% +$31.2K ﹤0.01% 5116
2023
Q3
$848K Buy
123,850
+103,840
+519% +$711K ﹤0.01% 2775
2023
Q2
$208K Sell
20,010
-8,466
-30% -$87.8K ﹤0.01% 4616
2023
Q1
$230K Buy
+28,476
New +$230K ﹤0.01% 4708
2022
Q4
Sell
-22,536
Closed -$355K 5756
2022
Q3
$355K Buy
+22,536
New +$355K ﹤0.01% 4013
2022
Q2
Sell
-29,100
Closed -$502K 5730
2022
Q1
$502K Buy
29,100
+5,409
+23% +$93.3K ﹤0.01% 3705
2021
Q4
$344K Buy
23,691
+10,574
+81% +$154K ﹤0.01% 4319
2021
Q3
$236K Sell
13,117
-58,347
-82% -$1.05M ﹤0.01% 4534
2021
Q2
$1.26M Sell
71,464
-376,171
-84% -$6.61M ﹤0.01% 2675
2021
Q1
$11.3M Buy
447,635
+337,086
+305% +$8.49M ﹤0.01% 717
2020
Q4
$715K Buy
+110,549
New +$715K ﹤0.01% 2994
2020
Q3
Hold
0
4370
2020
Q1
Sell
-30,642
Closed -$58K 4500
2019
Q4
$58K Buy
30,642
+2,157
+8% +$4.08K ﹤0.01% 3754
2019
Q3
$31K Sell
28,485
-42,408
-60% -$46.2K ﹤0.01% 4255
2019
Q2
$155K Buy
70,893
+55,923
+374% +$122K ﹤0.01% 4004
2019
Q1
$90K Buy
+14,970
New +$90K ﹤0.01% 2695
2018
Q3
Sell
-23,032
Closed -$460K 3270
2018
Q2
$460K Buy
23,032
+10,334
+81% +$206K ﹤0.01% 2282
2018
Q1
$222K Sell
12,698
-60,396
-83% -$1.06M ﹤0.01% 2753
2017
Q4
$1.8M Buy
+73,094
New +$1.8M ﹤0.01% 1211
2017
Q3
Hold
0
3095
2017
Q2
Sell
-33,793
Closed -$1.01M 3463
2017
Q1
$1.01M Buy
+33,793
New +$1.01M ﹤0.01% 1661